Unified Molecular Sequence And Structure Visualization Interface

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing computer systems for molecular design and analysis are divided into small-molecule and large-molecule domains, which are largely incompatible and do not interact, making it difficult to efficiently visualize and compare structural variants of complex molecules that require both sequence-based and structure-based aspects.

Innovation Solution

A bioinformatics platform that generates user interface presentations merging structure-oriented and sequence-oriented data, allowing researchers to view and modify both aspects of molecular entities in a unified interface, integrating data from separate database systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If separate database systems are used for small-molecule and large-molecule domains, then each domain can be optimized independently, but the systems become incompatible and cannot interact

Engineering Contradiction:
Improvedomain optimizationVSAvoidsystem compatibility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent merges separate small-molecule and large-molecule database systems into a unified bioinformatics platform that can handle both domains simultaneously. The system integrates structure-oriented data (small molecules) and sequence-oriented data (large molecules) into a single interface, allowing researchers to work with hybrid molecular entities like siRNA that require both types of information.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The unified interface provides universal functionality to handle multiple molecular domains and data types. The system can process and visualize both atomic structures and molecular sequences within the same platform, making it adaptable to various research needs involving complex molecular entities that bridge small and large molecule domains.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Manufacturing precision

If structure-oriented systems are used for small molecules, then atomic structure can be visualized, but sequence-based aspects are lost

Engineering Contradiction:
Improveatomic structure visualizationVSAvoidsequence information
Core Design Contradiction:
Manufacturing precisionVSLoss of information

Solution Approach 1:

The system combines structure-oriented visualization capabilities with sequence-oriented information display in a unified interface. When visualizing molecular entities, the platform simultaneously presents atomic structure details and molecular sequence data, ensuring that neither type of information is lost or excluded.

Inventive Principle:
Principle #5Merging (Combining)

3Loss of information

If sequence-oriented systems are used for large molecules, then molecular sequences can be analyzed, but atomic structure details are lost

Engineering Contradiction:
Improvesequence analysis capabilityVSAvoidatomic structure detail
Core Design Contradiction:
Loss of informationVSManufacturing precision

Solution Approach 1:

The unified bioinformatics platform merges sequence-oriented analysis capabilities with structure-oriented visualization. The system can display and analyze molecular sequences while simultaneously providing atomic structure details and attachment molecule visualizations, ensuring comprehensive information is available for hybrid molecular entities.

Inventive Principle:
Principle #5Merging (Combining)

4Adaptability or versatility

If unified interface is created for both domains, then both structure and sequence can be visualized, but system complexity increases

Engineering Contradiction:
Improveunified interface capabilityVSAvoidsystem architecture
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent introduces a unified interface as an intermediary layer that manages the complexity of integrating multiple data types and domains. This interface acts as a mediator between different data sources and the user, providing a consistent way to access and visualize both structure-oriented and sequence-oriented information without exposing the underlying system complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

5Loss of information

If detailed structural modeling is implemented, then richer dataset of associations is obtained, but computational resources required increase

Engineering Contradiction:
Improvedataset richnessVSAvoidcomputational resource consumption
Core Design Contradiction:
Loss of informationVSUse of energy by moving object

Solution Approach 1:

The system segments the molecular entity into distinct components (core structure, attachment molecules, linkers) and processes each segment separately. This allows detailed structural modeling of only the necessary components rather than the entire molecular entity, reducing computational resource requirements while maintaining rich dataset associations for each segment.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20250322903A1Visualizations of molecular sequences and structures
Publication Date: 2025.10.16 BENCHLING INC
  • US20250322903A1 patent drawing
  • US20250322903A1 patent drawing
  • US20250322903A1 patent drawing

AI summary

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for visualizing molecular sequences and structures. One of the methods includes receiving, from a sequence-oriented collection, data representing a sequence of molecular components, wherein the data specifies a different respective value for each of the molecular components in the sequence. Data representing an attachment molecule that is to be connected to one of the molecular components in the sequence is received from a structure-oriented collection. A user interface presentation that displays the sequence of molecular components using a different graphical representation for each molecular component of the sequence and that visually distinguishes a particular molecular component to which the attachment molecule is connected is generated.